Editor-in-Chief: Prof. Dr. Bilal Ahmad Rahimi
The Razi International Medical Journal subscribes the principles of the Committee on Publication Ethics (COPE).
The Razi International Medical Journal founded in 2021 is an independently peer-reviewed scholarly journal from Afghanistan that aims to impact public health and global health and is distributed internationally. The journal is produced and published in electronic and paper-based form biannually, and there is no article publishing charge (APCs).
Manuscript Submission Checklist
Please ensure that all the items listed below have been checked and uploaded with your submission before submitting your manuscript to the journal. Please contact the publisher directly in case you have any questions at firstname.lastname@example.org.
Razi International Medical Journal publishes a range of article types with the following specifications:
The reference system for our journal is Vancouver. You should write the reference numbers (in parentheses) as they enter the text and arrange them in the Reference section to their entrance in the text not alphabetical.
Article: Bloom BR. The future of public health. nature. 1999 Dec;402(6761):C63-4.
Chapter: Hillyer GV (1998). Immunodiagnosis of human and animal fasciolosis. In: Fasciolosis. Ed, JP Dalton. CABI Publishing, 1st Oxon, Wallingford, UK, pp. 435-48.
Book: Charmaz K (1991). Good days, bad days: The self in chronic illness and time. 2nd ed. New Brunswick: Rutgers University Press. New York.
Monograph on the Internet: Lundstedt S (2003). Analysis of PAHs and their transformation products in contaminated soil and remedial processes. University of Amsterdam, the Netherlands. www.google.com
Thesis: Mohammadi MM. Infant sleep and feeding [PhD thesis]. School of Public Health, Tehran University of Medical Sciences, Iran; 2002.
The relevant Ethics committee must approve the study (if applicable). The study itself should follow the ethical standards of the Helsinki Declaration, as revised in 2013 (available at http://www.wma.net/en/30publications/10policies/b3/).
Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials, or hospital numbers, especially reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. RIMJ will not consider any paper, which is ethically unacceptable. The related items should be inserted under the ‘Materials and Methods section.
All authors are strongly recommended to check their manuscripts content before its submission to the Razi International Medical Journal for publication. As of April 2022, all submitted papers to the journal will be checked against Plagiarism upon receiving and also before publishing finally using Turnitin & other Plagiarism Detection Softwares. If the Reviewers, Editor-in-Chief, Readers or Editorial Staffs suspect or notice any types of plagiarism at any stage of publication process, the manuscript will be rejected and all authors including the corresponding author will be notified then. Self-plagiarism is also considered & managed accordingly.
All articles published in the Razi International Medical Journal are open access, meaning that they are freely, immediately, and permanently accessible on the Razi International Medical Journal content platform. A Creative Commons (CC) user license defines how end users can subsequently reuse the articles. All articles in the Razi International Medical Journal are published under the CC BY-NC-ND 4.0 license. Note that Authors must accept this CC license upon submission of their paper.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
All the works in the Razi International Medical Journal (RIMJ) are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.